Synchron
PrivateLast Round
Series D
Nov 6, 2025
Total Funding Raised
$325M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Synchron is a neurotechnology company that develops an implantable brain-computer interface to interpret brain signals for treating conditions like paralysis, epilepsy, and movement disorders through a minimally invasive device.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Medical AI, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales, Government Contracts, Hardware + Subscription, Services & Consulting
AI Layer
Infrastructure
Keywords
Price History
Caplight MarketPrice™ estimate for Synchron, published with a 90-day delay.
Caplight MarketPrice™
$44.48
per share, as of March 2026
+20.0%
6-month change
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Synchron Comparables
Compare Synchron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paradromics | 89% | |
| Precision Neuroscience | 86% | |
| Neuralink | 84% | |
Synchron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 6, 2025 | ||||
| Series C | Dec 15, 2022 | ||||
| Series B | Jun 3, 2021 | ||||
| Series A | Apr 4, 2017 |
Synchron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forepont Capital Partners | Series B, Series C |
| Greenoaks Capital Partners | Series C |
| Khosla Ventures | Series C, Series D, Series B |
| U.S. Department of Defense | Series A |
| Bezos Expeditions | Series C, Series D |
| re.Mind Capital | Series B |
| T.Rx Capital | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Named to Fast Company's Most Innovative Companies list.
- Mar 24, 2026
Named to Fast Company's Most Innovative Companies list for 2026.
Synchron Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synchron's valuation, stock price, and market status.